Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart.
The acute adaptation of myocardial glucose metabolism in response to low-flow ischemia and reperfusion was investigated in isolated working rat hearts perfused with bicarbonate saline containing glucose (10 mM) and insulin (40 microU/ml). Reversible low-flow ischemia was induced by reducing coronary perfusion pressure from 100 to 35 cmH2O. Tritiated glucose was used to assess rates of glucose transport and phosphorylation, flux from glucose to pyruvate, and oxidation of exogenous glucose. Rates of glycogen synthesis and glycolysis were also assessed. With ischemia, cardiac power decreased by more than two-thirds. Rates of glucose uptake and flux from glucose to pyruvate remained unchanged, while glucose oxidation declined by 61%. Rates of lactate release more than doubled, and fractional enrichment of glycogen remained the same. During reperfusion, glucose oxidation returned to the preischemic values. When isoproterenol was added during ischemia, glucose uptake increased, glycogen decreased, and lactate release increased. No effect was seen with pacing. We conclude that during low-flow ischemia and with glucose as the only exogenous substrate, net glucose uptake remains unchanged. There is a reversible redirection between glycolysis and glucose oxidation, while glycogen synthesis continues during ischemia and is enhanced with reperfusion.
Bolukoglu
H
H
Department of Internal Medicine, University of Texas Houston Medical School 77030, USA.
Goodwin
G W
GW
Guthrie
P H
PH
Carmical
S G
SG
Chen
T M
TM
Taegtmeyer
H
H
D000818:Animals; D002316:Cardiotonic Agents; D005947:Glucose / Q000378:metabolism*; D006339:Heart Rate; D007545:Isoproterenol / Q000008:administration & dosage; D008297:Male; D017202:Myocardial Ischemia / Q000378:metabolism*; D015428:Myocardial Reperfusion Injury / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow
D002316:Cardiotonic Agents; D005947:Glucose; D007545:Isoproterenol